MedTrace Logo

Treatment of Patients Suffering From Nervous Restlessness With PASCOFLAIR®

NCT02651922 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 154

Last updated 2024-07-30

Study results available
· View outcomes & findings →

Summary

The study was carried out as a prospective, non-interventional study with the intention of subsequent process cost analyses (PCA) and also considers quality of life, drug misuse, dependence, adverse events and therapy satisfaction.

Conditions

  • Nervous Restlessness

Sponsors & Collaborators

  • Institut für Empirische Gesundheitsökonomie, Prof. Dr. Dr.med. Reinhard Rychlik,Am Ziegelfeld 28,51399 Burscheid,Germany

    collaborator UNKNOWN

  • Pascoe Pharmazeutische Praeparate GmbH

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-06-30
Completion
2015-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02651922 on ClinicalTrials.gov